Intrinsic Value of S&P & Nasdaq Contact Us

InflaRx N.V. IFRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • DE • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.00
+65.3%

There have been 6 recent insider transactions recorded for InflaRx N.V. (IFRX), including 0 buys and 0 sells.

Notable insiders with recent activity include Riedemann Niels, Gibney Anthony S, Kubler Mark. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — IFRX

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-03-18 Riedemann Niels Chief Executive Officer Unknown 190,500 $1.17 $222.89K -
2026-03-18 Gibney Anthony S Director Unknown 30,000 $1.17 $35.1K -
2026-03-18 Kubler Mark Director Unknown 30,000 $1.17 $35.1K -
2026-03-18 Fulpius Nicolas Director Unknown 45,000 $1.17 $52.65K -
2026-03-18 Ocarroll Derval See Remarks Unknown 21,000 $1.17 $24.57K -
2026-03-18 Taapken Thomas Chief Financial Officer Unknown 72,000 $1.17 $84.24K -
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message